Table 5. Association of urinary collagen fragments with serum biomarkers of collagen turnover.
Urinary marker (SD) | Collagen I | Urinary marker (SD) | Collagen III | ||
---|---|---|---|---|---|
Serum markers | Estimate (95% CI) | p | Serum markers | Estimate (95% CI) | p |
p73697 (521) | p107460 (863) | ||||
PICP, μg/L | 14.9 (12.0 to 17.8) | <0.0001 | PICP, μg/L | –5.39 (–8.47 to –2.31) | 0.0006 |
CITP, μg/L | 0.31 (0.16 to 0.47) | <0.0001 | CITP, μg/L | –0.62 (–0.76 to –0.47) | <0.0001 |
PIIINP, % | 4.63 (1.77 to 7.50) | 0.0016 | TIMP-1, ng/mL | –30.9 (–43.9 to –18.0) | <0.0001 |
p77018 (1504) | p112106 (3149) | ||||
TIMP-1, ng/mL | 21.4 (8.36 to 34.5) | 0.0013 | CITP, μg/L | –0.44 (–0.59 to –0.29) | <0.0001 |
p77763 (991) | |||||
TIMP-1, ng/mL | 39.4 (26.5 to 52.2) | <0.0001 |
Abbreviations: CI, confidence interval; PICP, carboxyterminal propeptide of procollagen I; CITP, carboxyterminal telopeptide of collagen I; TIMP-1, tissue inhibitor of the matrix metalloproteinase type 1; PIIINP, aminoterminal propeptide of procollagen type III. Estimates express the change in the serum biomarkers per 1-SD increase in urinary collagen fragments. The urinary peptides were identified in the continuous analyses (S1 Fig and Table 3) with the exception of p77763, which was a marker of diastolic LV dysfunction in the PLS-DA analysis (Fig 2) and had an amino-acid sequence very similar to that of p77018 (one proline residue being replaced by hydroxyproline; S2 Table).